Detalhe da pesquisa
1.
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection.
Int J Mol Sci;
23(19)2022 Sep 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36232827
2.
Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns.
Oncologist;
26(9): 787-796, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34080753
3.
Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study.
Oncologist;
25(5): e808-e815, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31740568
4.
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
JAMA;
321(14): 1370-1379, 2019 04 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30964527
5.
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.
Lancet Oncol;
18(4): 446-453, 2017 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28223062
6.
Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures.
J Vasc Interv Radiol;
28(11): 1487-1494, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28912090
7.
The Parity Paradigm: Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications?
Value Health;
19(1): 88-98, 2016 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26797241
8.
Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial?
Curr Treat Options Oncol;
17(6): 26, 2016 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27098532
9.
Cost estimates and economic implications of expanded RAS testing in metastatic colorectal cancer.
Oncologist;
20(1): 14-8, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25410095
10.
Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Oncologist;
20(6): 615-6, 2015 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25926352
11.
Impact of Medicare Part D on out-of-pocket drug costs and medical use for patients with cancer.
Cancer;
120(21): 3378-84, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24962682
12.
Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.
Eur J Nucl Med Mol Imaging;
41(10): 1861-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24906565
13.
Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort.
JAMA Netw Open;
7(1): e2351700, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38252441
14.
Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204.
Cancer;
119(8): 1521-7, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23288663
15.
Health care disparities in the treatment of colorectal cancer.
Curr Treat Options Oncol;
14(3): 405-14, 2013 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23793562
16.
Exploring Barriers to Pediatric Cancer Clinical Trials: The Role of a Networked, Just-in-Time Study Program.
Clin Ther;
45(11): 1148-1150, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37783645
17.
Assessment of Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy.
JAMA Netw Open;
6(5): e2311181, 2023 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37129893
18.
Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumab.
Mol Oncol;
17(2): 298-311, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36426653
19.
Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitoring assay.
Front Oncol;
13: 1221718, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37601688
20.
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).
J Clin Oncol;
41(7): 1359-1369, 2023 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36260828